Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −289 $316.55 $91K 23,223
2026-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −282 $318.62 $90K 22,941
2026-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −722 $320.51 $231K 22,219
2026-03-03 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale 10b5-1 −359 $321.58 $115K 21,860
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award +4,769 66,479
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −65 $323.62 $21K 66,414
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −124 $324.65 $40K 66,290
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −356 $325.63 $116K 65,934
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −541 $326.81 $177K 65,393
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −454 $327.67 $149K 64,939
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −138 $328.71 $45K 64,801
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −234 $329.71 $77K 64,567
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −112 $330.85 $37K 64,455
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −129 $331.93 $43K 64,326
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Sale −53 $332.64 $18K 64,273
2026-03-02 Poulton Jeffrey V. EVP, Chief Financial Officer Grant or award · Stock Option (right to buy) +10,480 10,480
2026-03-02 Garg Pushkal EVP Chief R&D Grant or award 10b5-1 +4,769 26,898
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −50 $323.62 $16K 26,848
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −97 $324.65 $31K 26,751
2026-03-02 Garg Pushkal EVP Chief R&D Sale 10b5-1 −277 $325.63 $90K 26,474

Page 6 of 41 · 816 trades